GEN Exclusives

More »

GEN News Highlights

More »
Mar 26, 2009

Center for Translational Pathology Purchases Genomatix’ Next-Gen Sequencing Analysis Systems

  • The Center for Translational Pathology at the University of Michigan installed a Genomatix Mining Station (GMS) and a Genomatix Genome Analyzer (GGA) at its labs in Ann Arbor, MI. The two technologies work in conjunction to provide an analysis of next-generation sequencing data.

    GMS is based on a genomic pattern recognition paradigm, or GenomeThesaurus, which allows for input of raw sequence reads plus optional quality files from any sequencing hardware. GGA delivers downstream software tools and databases for the analysis of GMS data.

    GMS reportedly provides ultrafast mapping of sequences of any length (starting from 8 bp) with no practical limits on the number of point mutations and/or insertions and deletions that can be taken into account during the mapping process. Depending on the nature of the experiment, the GMS can provide SNP detection and genotyping, copy number analysis, and small RNA analysis.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Alzheimer's Therapies

Do you think an effective treatment for Alzheimer’s will be found within the next 10–15 years?